No rejected requests under GSK transparency initiative

As of Sept. 20, five research proposals requesting patient-level data from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) under the pharma's January open access initiative

Read the full 220 word article

How to gain access

Continue reading with a
two-week free trial.